Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dr. Reddy's
Pharma
AstraZeneca-Alteogen, Taiho, WuXi—Fierce Pharma Asia
AZ taps Alteogen to develop subcutaneous cancer drugs. Taiho acquires ADC expert Araris Biotech. WuXi AppTec expects sales growth in 2025. And more.
Angus Liu
Mar 21, 2025 9:10am
Dr. Reddy's, Sun and Zydus issue separate drug recalls in the US
Mar 17, 2025 11:52am
AZ China fallout, Pfizer's $1B plan in China—Fierce Pharma Asia
Nov 8, 2024 8:54am
Journey’s Emrosi rosacea treatment is FDA cleared for takeoff
Nov 4, 2024 10:50am
Dr. Reddy’s recalls thyroid drug over carcinogen concerns
Nov 4, 2024 9:58am
Astellas, AstraZeneca, Glenmark and more—Fierce Pharma Asia
Sep 6, 2024 9:00am
